WHO bans SA manufactured generics
AFP reported that the WHO said it had sent an official “Notice of Concern” letter to Sandoz on September 12 after an inspection of the unit’s Kempton Park factory in South Africa.
That had revealed 41 separate cases classified as “non-compliances and deviations from the WHO Good Manufacturing Practices.”
For example, “the company failed to ensure that where starting and primary packaging materials and intermediate or bulk products were exposed to the environment, interior surfaces were not smooth and free from cracks and open joints, and did not permit easy and effective cleaning and, if necessary, disinfection,” the WHO said in its letter.
The inspection was carried out in May, said the WHO.
Since then however, Sandoz had failed to take sufficient steps to remedy the situation and thus the WHO has deemed the Kempton Park site to be “operating not in compliance with WHO GMP.”
As such, the WHO would “recommend suspension of procurement of all prequalified products manufactured at this site, (and) withhold prequalification of all new products,” the letter said.
These recommendations would remain in force “until satisfactory corrective actions have been implemented by the manufacturer and verified by WHO,” it added. – AFP
Author
-
Health-e News is South Africa's dedicated health news service and home to OurHealth citizen journalism. Follow us on Twitter @HealtheNews
Republish this article
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Unless otherwise noted, you can republish our articles for free under a Creative Commons license. Here’s what you need to know:
-
You have to credit Health-e News. In the byline, we prefer “Author Name, Publication.” At the top of the text of your story, include a line that reads: “This story was originally published by Health-e News.” You must link the word “Health-e News” to the original URL of the story.
-
You must include all of the links from our story, including our newsletter sign up link.
-
If you use canonical metadata, please use the Health-e News URL. For more information about canonical metadata, click here.
-
You can’t edit our material, except to reflect relative changes in time, location and editorial style. (For example, “yesterday” can be changed to “last week”)
-
You have no rights to sell, license, syndicate, or otherwise represent yourself as the authorized owner of our material to any third parties. This means that you cannot actively publish or submit our work for syndication to third party platforms or apps like Apple News or Google News. Health-e News understands that publishers cannot fully control when certain third parties automatically summarise or crawl content from publishers’ own sites.
-
You can’t republish our material wholesale, or automatically; you need to select stories to be republished individually.
-
If you share republished stories on social media, we’d appreciate being tagged in your posts. You can find us on Twitter @HealthENews, Instagram @healthenews, and Facebook Health-e News Service.
You can grab HTML code for our stories easily. Click on the Creative Commons logo on our stories. You’ll find it with the other share buttons.
If you have any other questions, contact info@health-e.org.za.
WHO bans SA manufactured generics
by healthe, Health-e News
September 23, 2008